Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine and Lidocaine Combination for Pain Control in Percutaneous Radiological Gastrostomy
NCT04250805Phase 2Terminated
- Sponsor
- CHU Saint-Etienne
- Start
- Oct 2020
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of ropivacaine in procedural pain (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Level of Pain at 24 hours. Started Oct 2020; status: terminated.
02
Drugs
ropivacaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT04250805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04250805.